Cargando…

HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC

BACKGROUND: Immune checkpoint blockade (ICB) only works well for a certain subset of patients with non-small cell lung cancer (NSCLC). Therefore, biomarkers for patient stratification are desired, which can suggest the most beneficial treatment. METHODS: In this study, three datasets (GSE126044, GSE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Jie, Jiang, Guanyu, Chen, Yundi, Xu, Yongrui, Wan, Yuan, Chen, Ruo, Liu, Feng, Mao, Wenjun, Zheng, Mingfeng, Xu, Junying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258174/ https://www.ncbi.nlm.nih.gov/pubmed/35794593 http://dx.doi.org/10.1186/s12885-022-09840-6

Ejemplares similares

GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC
por: Fan, Honghong, et al.
Publicado: (2023)

New biomarker: the gene HLA-DRA associated with low-grade glioma prognosis
por: Chen, Desheng, et al.
Publicado: (2022)

HLA-DRA Gene Polymorphisms Are Associated with Graves' Disease as an Autoimmune Thyroid Disease
por: Du, Peng, et al.
Publicado: (2022)

Expression of mRNA levels of HLA-DRA in relation to monocyte HLA-DR: a longitudinal sepsis study
por: Cajander, SC, et al.
Publicado: (2015)

Conjunctival Inflammatory Gene Expression Profiling in Dry Eye Disease: Correlations With HLA-DRA and HLA-DRB1
por: Kessal, Karima, et al.
Publicado: (2018)

Multiple Histone Methyl and Acetyltransferase Complex Components Bind the HLA-DRA Gene
por: Choi, Nancy M., et al.
Publicado: (2012)

CD74 and HLA-DRA in Cervical Carcinogenesis: Potential Targets for Antitumour Therapy
por: Balakrishnan, Carol K., et al.
Publicado: (2022)

Establishment and validation of nomograms for predicting survival of lung invasive adenocarcinoma based on the level of pathological differentiation: a SEER cohort-based analysis
por: Wang, Xiaokun, et al.
Publicado: (2023)

C3, C3AR1, HLA-DRA, and HLA-E as potential prognostic biomarkers for renal clear cell carcinoma
por: Chu, Guangdi, et al.
Publicado: (2020)

Tumor mutational load, CD8(+) T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients
por: Hurkmans, Daan P., et al.
Publicado: (2020)

Absent in Melanoma 2 (AIM2) is an important mediator of interferon-dependent and -independent HLA-DRA and HLA-DRB gene expression in colorectal cancers
por: Lee, J, et al.
Publicado: (2012)

Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosis
por: Chan, Kuan Rong, et al.
Publicado: (2023)

Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis
por: Cajander, Sara, et al.
Publicado: (2013)

Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer
por: Matsuzaki, Junko, et al.
Publicado: (2022)

Benchmarking HLA genotyping and clarifying HLA impact on survival in tumor immunotherapy
por: Li, Xiangyong, et al.
Publicado: (2021)

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
por: Dillard, Pierre, et al.
Publicado: (2021)

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
por: de Vries, Natasja L., et al.
Publicado: (2023)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants
Publicado: (1985)

Association of HLA-A and Non-Classical HLA Class I Alleles
por: Carlini, Federico, et al.
Publicado: (2016)

HLA Class II Genes HLA-DRB1, HLA-DPB1, and HLA-DQB1 Are Associated With the Antibody Response to Inactivated Japanese Encephalitis Vaccine
por: Yao, Yufeng, et al.
Publicado: (2019)

Shared Signature of Recent Positive Selection on the TSBP1–BTNL2–HLA-DRA Genes in Five Native Populations from North Borneo
por: Hoh, Boon-Peng, et al.
Publicado: (2020)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design
por: Doonan, Bently P, et al.
Publicado: (2015)

HLA class II transgenic mice: the chance to unravel the basis of HLA class II associations with disease
Publicado: (1994)

HLA-Clus: HLA class I clustering based on 3D structure
por: Shen, Yue, et al.
Publicado: (2023)

SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
por: Mei, Jie, et al.
Publicado: (2023)

SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
por: Mei, Jie, et al.
Publicado: (2023)

Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression
Publicado: (1995)

Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule
Publicado: (1990)

Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients
por: Huang, Xin, et al.
Publicado: (2010)

Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
por: Paulson, K. G., et al.
Publicado: (2018)

Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
por: Reimers, Marlies S, et al.
Publicado: (2014)

Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein
por: Smith, Kathrine J., et al.
Publicado: (1998)

iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity
por: Suzuki, Daisuke, et al.
Publicado: (2019)

Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children
por: Ruiz-Extremera, A., et al.
Publicado: (2017)

Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?
por: Ravindranath, Mepur H., et al.
Publicado: (2023)

Identification of adenoid subtype characterized with immune-escaped phenotype in lung squamous carcinoma based on transcriptomics
por: Mei, Jie, et al.
Publicado: (2022)

Recurrent lung adenocarcinoma benefits from microwave ablation following multidisciplinary treatments: A case with long-term survival
por: Jiang, Guanyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u8pnr8lei9utegovfe7q4gvjia